Sabin Vaccine Institute
The Sabin Vaccine Institute ("Sabin") is a non-profit, 501(c)(3) organization dedicated to reducing needless human suffering from vaccine preventable and neglected tropical diseases through prevention and treatment. Sabin advocates for the control of infectious diseases such as HPV, pneumococcal disease, pertussis, rotavirus, rubella, and typhoid and neglected tropical diseases (NTDs) including human hookworm infection, ascariasis, trichuriasis, schistosomiasis, onchocerciasis, lymphatic filariasis (elephantiasis), and trachoma. The Sabin Vaccine Institute was founded in 1993 by Dr. H.R. Shepherd, Mrs. Heloisa Sabin, Dr. Robert M. Chanock, and Dr. Philip K. Russell and named in honor of one of medicine’s most pre-eminent scientific figures, Dr. Albert B. Sabin, best known for developing the oral live virus polio vaccine. The Institute continues Dr. Sabin’s vision by providing greater access to vaccines and essential treatments for hundreds of millions of people stuck in a cycle of pain, poverty and despair through its three main programs – Sabin Vaccine Development, the Global Network for Neglected Tropical Diseases, and Vaccine Advocacy and Education.
New study suggests potential shift in burden of pneumococcal disease
New studies revealed today by Latin American researchers and global health leaders suggest that the highest burden of deadly pneumococcal disease in Latin America may be shifting to adults as countries successfully immunize ...
Diseases, Conditions, Syndromes
Mar 05, 2013 |
not rated yet |
0
New study highlights Chagas disease as a growing health and socio-economic challenge
Today, The Lancet Infectious Diseases published a new report that examines the global economic burden of Chagas disease. In the first study of its kind, researchers measured the health and economic impact of Chagas diseas ...
Diseases, Conditions, Syndromes
Feb 07, 2013 |
5 / 5 (1) |
0
Integrated neglected tropical disease control and elimination programs: A global health 'best buy'
A recently released report, entitled "Social and Economic Impact Review on Neglected Tropical Diseases," highlights links between neglected tropical diseases (NTDs) and socio-economic prosperity. Published by Hudson Institute's ...
Diseases, Conditions, Syndromes
Jan 17, 2013 |
not rated yet |
0
Clinical trials for first-ever human hookworm vaccine advance
The Sabin Vaccine Institute (Sabin) today announced the start of Part II of its Phase I clinical trial of the Na-GST-1 vaccine candidate, marking another major milestone in the progress toward developing a human hookworm ...
Medications
Nov 05, 2012 |
not rated yet |
0
Concerns over cost of dengue vaccine lessened with new study
Research funded by the Dengue Vaccine Initiative (DVI) involving an economic analysis of producing a tetravalent dengue vaccine shows that the cost could be as low as $0.20 per dose with an annual production level of 60 million ...
Medications
Jun 28, 2012 |
not rated yet |
0
Clinical trial of human hookworm vaccine begins at Children's National Medical Center
Today, the Sabin Vaccine Institute, in partnership with the George Washington University and the Children's National Medical Center, began vaccinating participants for a Phase 1 clinical trial of a novel human hookworm vaccine. ...
Medications
Jun 13, 2012 |
not rated yet |
0
World Health Assembly endorses new plan to increase global access to vaccines
Ministers of Health from 194 countries at the Sixty-fifth World Health Assembly today endorsed a landmark Global Vaccine Action Plan (GVAP), a roadmap to prevent millions of deaths by 2020 through more equitable access to ...
Diseases, Conditions, Syndromes
May 25, 2012 |
not rated yet |
1